company background image
8329 logo

Shenzhen Neptunus Interlong Bio-technique SEHK:8329 Stock Report

Last Price

HK$0.16

Market Cap

HK$265.1m

7D

-1.9%

1Y

-11.7%

Updated

28 Mar, 2024

Data

Company Financials

Shenzhen Neptunus Interlong Bio-technique Company Limited

SEHK:8329 Stock Report

Market Cap: HK$265.1m

8329 Stock Overview

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines and medical devices in the People’s Republic of China.

8329 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends0/6

Shenzhen Neptunus Interlong Bio-technique Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenzhen Neptunus Interlong Bio-technique
Historical stock prices
Current Share PriceHK$0.16
52 Week HighHK$0.18
52 Week LowHK$0.13
Beta0.18
1 Month Change1.28%
3 Month Change-3.66%
1 Year Change-11.73%
3 Year Change-36.80%
5 Year Change-49.03%
Change since IPO-56.71%

Recent News & Updates

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Recent updates

These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Oct 03
These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

Mar 29
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?

We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

Sep 28
We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt

A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Aug 18
A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Jun 06
Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?

Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Dec 15
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?

Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Dec 29
Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.

Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Nov 24
Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly

Shareholder Returns

8329HK PharmaceuticalsHK Market
7D-1.9%-0.8%-0.6%
1Y-11.7%-11.4%-14.0%

Return vs Industry: 8329 matched the Hong Kong Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 8329 exceeded the Hong Kong Market which returned -14% over the past year.

Price Volatility

Is 8329's price volatile compared to industry and market?
8329 volatility
8329 Average Weekly Movement7.3%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement7.3%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 8329 has not had significant price volatility in the past 3 months.

Volatility Over Time: 8329's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,453n/ahttps://www.interlong.com

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, researches, develops, produces, and sells medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business.

Shenzhen Neptunus Interlong Bio-technique Company Limited Fundamentals Summary

How do Shenzhen Neptunus Interlong Bio-technique's earnings and revenue compare to its market cap?
8329 fundamental statistics
Market capHK$265.12m
Earnings (TTM)HK$26.12m
Revenue (TTM)HK$1.15b

10.2x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8329 income statement (TTM)
RevenueCN¥1.06b
Cost of RevenueCN¥617.35m
Gross ProfitCN¥447.51m
Other ExpensesCN¥423.38m
EarningsCN¥24.13m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.014
Gross Margin42.03%
Net Profit Margin2.27%
Debt/Equity Ratio8.6%

How did 8329 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.